Kura Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Kura Oncology and other ETFs, options, and stocks.About KURA
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias.
KURA Key Statistics
Stock Snapshot
The current Kura Oncology(KURA) stock price is $8.39, with a market capitalization of 740.61M. The stock trades at a price-to-earnings (P/E) ratio of -3.35.
On 2026-02-15, Kura Oncology(KURA) stock traded between a low of $8.00 and a high of $8.40. Shares are currently priced at $8.39, which is +4.9% above the low and -0.1% below the high.
Kura Oncology(KURA) shares are trading with a volume of 2.67M, against a daily average of 1.38M.
During the past year, Kura Oncology(KURA) stock moved between $5.41 at its lowest and $12.49 at its peak.
During the past year, Kura Oncology(KURA) stock moved between $5.41 at its lowest and $12.49 at its peak.
Analyst ratings
87%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.